About conolidine
Andy Chevigné and his staff, RTI-5152-12 is postulated to enhance the levels of opioid peptides that bind to classical opioid receptors within the Mind, leading to heightened painkilling action. The LIH-RTI investigation teams recognized a collaboration settlement and submitted a joint patent application in December 2020.At that time, Microsoft Ad